Investors

Next-gen defense to combat transmission and infection.

Our technology helps filter and deactivate pathogens to reduce the risk of transmission, making indoor spaces, higher risk work environments and social interactions safer— especially for those most vulnerable.

Advancing rapid detection and diagnostics.

Our cutting-edge nanotechnology offers fast, affordable, non-invasive, scalable point-of-care detection for numerous pathogens, including viruses like SARS-CoV-2, empowering governments, health agencies and individuals worldwide to identify infections and end outbreaks faster than ever before.

Enhancing recovery and health outcomes.

We are developing breakthrough antimicrobial therapies so people can recover faster and live their lives to the fullest. Testing to date has shown our nanotech-powered therapies are safe and effective against numerous pathogens and can potentially transform modalities in medicine across the globe.